ASCOR
Live / Registered — Registered — Section 8 accepted (as of 06 Dec 2023)
What this means for you
Registered since 03 Apr 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87052669
- Registration number
- 5438861
- Mark type
- Stylized text
- Filed
- 27 May 2016
- Published for opposition
- 25 Oct 2016
- Registered
- 03 Apr 2018
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of scurvy, namely, ascorbic acid for injection
Owner
- McGuff Pharmaceuticals, Inc., Santa Ana, CA, US
- McGuff Pharmaceuticals, Inc., Santa Ana, CA, US
- McGuff Pharmaceuticals, Inc., Santa Ana, CA, US
Prosecution history
- 06 Dec 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 06 Dec 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 30 Nov 2023 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 07 Nov 2023 — POST REGISTRATION ACTION MAILED - SEC. 8
- 24 Oct 2023 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 11 Sept 2023 — POST REGISTRATION ACTION MAILED - SEC. 8
- 05 Sept 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 Apr 2023 — TEAS SECTION 8 RECEIVED
- 03 Apr 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 03 Apr 2018 — REGISTERED-PRINCIPAL REGISTER
- 27 Feb 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Feb 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Feb 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Feb 2018 — USE AMENDMENT FILED
- 15 Feb 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL